Jay . Thanks for the reply . The document you posted shows the APA is for substantially all assets ( including inventory and IP) and also assumes most contracts to Taran . What will be left in Humanigen ? . I am assuming you believe there will be another potential merger between Taran and humanigen which will cover/ protect the shareholders of humanigen . I am hoping that’s the case . But why would Taran do it ?
Sorry I forgot the only thing excluded from APA is the foreign subsidiary. I hope that’s enough in value for a favorable merger with Taran on terms favorable for humanigen shareholders .